PDG88 COST-UTILITY ANALYSIS OF ABIRATERONE VERSUS...

PDG88 COST-UTILITY ANALYSIS OF ABIRATERONE VERSUS ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER FAILURE OF ANDROGEN DEPRIVATION THERAPY

Silva Miguel, L., Paquete, A.T., Borges, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1101
Date:
November, 2019
File:
PDF, 651 KB
2019
Conversion to is in progress
Conversion to is failed